FDA approves new treatment for rare tumour
July 15, 2022Medical Communications
The FDA has approved crizotinib for adult and paediatric patients aged 1 year and older with unresectable, recurrent, or refractory …
First immunotherapy for untreated, unresectable malignant pleural mesothelioma recommended by NICE
July 14, 2022Business Services
Bristol Myers Squibb (BMS) has announced that the NICE Final Appraisal Document (FAD) recommending the combination of nivolumab plus ipilimumab …
Trodelvy recommended in England for metastatic triple negative breast cancer
July 14, 2022Business Services
Gilead Sciences has announced the NICE recommendation of Trodelvy (sacituzumab govitecan) for use on the NHS in England, as an …
Nucleai partners with Sirona Dx for AI-driven discovery of biomarkers in solid tumours
July 14, 2022Business Services
Nuclei and Sirona Dx have announced a collaboration to advance the discovery of novel spatial biomarkers in solid tumours.The partnership …
Gene editing potential treatment for hereditary killer
July 13, 2022Research and Development
Verve therapeutics has dosed the first patient win its heart-1 clinical trial, studying the safety and efficacy of its in …
FDA accepts Byondis’ Biologics License Application for breast cancer treatment
July 13, 2022Research and Development
The FDA has accepted Byondis’ submission of a Biologics License Application (BLA) for [vic-] trastuzumab duocarmazine (SYD985) in patients with …
Trial of mRNA first Nipah virus vaccine
July 13, 2022Research and Development
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage …
Health organisations warn monkeypox could become endemic in UK if action is not taken
July 13, 2022Research and Development
Leading sexual health organisations have warned that monkeypox could become endemic in the UK if the government does not take …
FDA approves Lipocine’s IND for adult epilepsy treatment
July 12, 2022Manufacturing and Production
The FDA has accepted Lipocine’s Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a …
NIH grant for research into functional cure for HIV
July 12, 2022Manufacturing and Production
The NIH has granted Oregon Health and Science Univerity (OHSU) a $5 million grant for the research of its one-time …
Vasopharm GmbH announces positive data from clinical trials in traumatic brain injury
July 12, 2022Manufacturing and Production
Vasopharm GmbH has announced the results of significantly reduced brain microdialyse lactate levels in the Phase II (NOSTRA) and Phase …
Application to FDA for first-ever over-the-counter birth control pill
July 12, 2022Manufacturing and Production
The FDA is due to consider whether oral birth control medication should be made available to consumers over the counter, …
Ghana records first ever suspected cases of Marburg virus disease
July 11, 2022Sales and Marketing
Health authorities in Ghana have shared that for the first time they have confirmed two fatal cases of the Marburg …
WHO and Kenya launch medical emergency hub in Nairobi
July 11, 2022Sales and Marketing
WHO and the Kenyan government have launched an emergency hub for public health risks in the country’s capital and largest …
Japanese study suggests parasitic worms could deliver anti-cancer therapies
July 8, 2022Medical Communications
Researchers from Osaka University have released details on how they discovered a unique potential treatment method for cancer: parasitic worms.The …
NICE recommends Nivolumab for invasive urothelial cancer
July 8, 2022Medical Communications
NICE has published final draft guidance recommending nivolumab for treating some people with invasive urothelial cancer at a high risk …
New funding announced to support future dementia research
July 8, 2022Medical Communications
The NIHR has introduced £11.8 million in funding for promising early career researchers to pursue dementia research. The institute, working …
Scientists discover key to hepatitis A replication
July 8, 2022Medical Communications
UNC School of Medicine scientists discovered the key to hepatitis A virus (HAV) replication. They also found an oral compound …
Destiny Pharma announces positive data from antibacterial treatment study
July 7, 2022Business Services
Destiny Pharma has announced the publication of new data on XF-73, which is shown to enhance the activity of two …
CardiaTec raises £1.4m to combat cardiovascular disease with AI
July 7, 2022Business Services
CardiaTec Biosciences has secured a £1.4 million pre-seed investment led by Laidlaw Scholars Ventures and APEX Ventures. The company is …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
